PRESS RELEASE published on 02/11/2026 at 09:00, 4 months 15 days ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY Aiforia Technologies Oyj advances with new Foundation Engine technology for medical imaging, aiming for improved accuracy and scalability. Analyst recommends BUY with €3.80 target price Medical Imaging Scalability Accuracy Aiforia Technologies Oyj Foundation Engine
BRIEF published on 12/12/2025 at 09:05, 6 months 14 days ago Aiforia Technologies renforce sa liquidité grâce à une émission d'actions Liquidité Économies De Coûts Émission D'actions Projections De Croissance Technologies Aiforia
BRIEF published on 12/12/2025 at 09:05, 6 months 14 days ago Aiforia Technologies Strengthens Liquidity with Share Issuance Liquidity Share Issuance Cost Savings Growth Projections Aiforia Technologies
PRESS RELEASE published on 12/12/2025 at 09:00, 6 months 14 days ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY Aiforia Technologies Oyj successfully completes directed share issuance, raising €4.2m to ease liquidity constraints. Company aims for sustainable cash generation with reduced operating expenses Cash Generation Operating Expenses Liquidity Constraints Aiforia Technologies Oyj Directed Share Issuance
BRIEF published on 10/23/2025 at 09:05, 8 months 3 days ago Aiforia Technologies Oyj Positioned as Pathology AI Leader Market Growth Diagnostic Accuracy Pathology AI Aiforia Technologies NuWays AG Rating
BRIEF published on 10/23/2025 at 09:05, 8 months 3 days ago Aiforia Technologies Oyj se positionne comme leader de l'IA en pathologie Croissance Du Marché Précision Du Diagnostic Aiforia Technologies IA De Pathologie Notation De NuWays AG
PRESS RELEASE published on 10/23/2025 at 09:00, 8 months 3 days ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY Aiforia Technologies Oyj receives Buy recommendation for disrupting pathology with AI technology, leading in cancer diagnostics with AI-powered platform for faster, more accurate diagnoses AI-powered Platform Buy Recommendation Cancer Diagnostics Aiforia Technologies Oyj Pathology AI Technology
Published on 06/27/2026 at 01:40, 6 hours 54 minutes ago Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 8 hours 34 minutes ago Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 9 hours 34 minutes ago Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 9 hours 44 minutes ago Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Published on 06/26/2026 at 22:15, 10 hours 19 minutes ago Revive Therapeutics Announces Proposed Private Placement
Published on 06/27/2026 at 00:05, 8 hours 29 minutes ago EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 8 hours 30 minutes ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 8 hours 58 minutes ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 8 hours 58 minutes ago EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Published on 06/26/2026 at 23:27, 9 hours 6 minutes ago EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE
Published on 06/26/2026 at 17:45, 14 hours 49 minutes ago Descriptif du programme de rachat d'actions
